1 Supplementary Materials Functional Analysis of 5
Total Page:16
File Type:pdf, Size:1020Kb
Load more
										Recommended publications
									
								- 
												
												The Splicing Factor U2AF1 Contributes to Cancer Progression Through a Noncanonical Role in Translation Regulation
Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation Murali Palangat,1 Dimitrios G. Anastasakis,2 Dennis Liang Fei,3 Katherine E. Lindblad,4 Robert Bradley,5 Christopher S. Hourigan,4 Markus Hafner,2 and Daniel R. Larson1 1Laboratory of Receptor Biology and Gene Expression, National Cancer Insitute, National Institutes of Health, Bethesda, Maryland 20892, USA; 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA; 3Weill Cornell Medicine, New York, New York 10065, USA; 4Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA; 5Computational Biology Program, Public Health Sciences and Biological Sciences, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA Somatic mutations in the genes encoding components of the spliceosome occur frequently in human neoplasms, including myeloid dysplasias and leukemias, and less often in solid tumors. One of the affected factors, U2AF1, is involved in splice site selection, and the most common change, S34F, alters a conserved nucleic acid-binding domain, recognition of the 3′ splice site, and alternative splicing of many mRNAs. However, the role that this mutation plays in oncogenesis is still unknown. Here, we uncovered a noncanonical function of U2AF1, showing that it directly binds mature mRNA in the cytoplasm and negatively regulates mRNA translation. This splicing- independent role of U2AF1 is altered by the S34F mutation, and polysome profiling indicates that the mutation affects translation of hundreds of mRNA. - 
												
												Genome Scale Metabolic Modeling of the Riboflavin Overproducer Ashbya Gossypii
Chalmers Publication Library Genome Scale Metabolic Modeling of the Riboflavin Overproducer Ashbya gossypii This document has been downloaded from Chalmers Publication Library (CPL). It is the author´s version of a work that was accepted for publication in: Biotechnology and Bioengineering (ISSN: 0006-3592) Citation for the published paper: Ledesma-Amaro, R. ; Kerkhoven, E. ; Revuelta, J. (2014) "Genome Scale Metabolic Modeling of the Riboflavin Overproducer Ashbya gossypii". Biotechnology and Bioengineering, vol. 111(6), pp. 1191-1199. http://dx.doi.org/10.1002/bit.25167 Downloaded from: http://publications.lib.chalmers.se/publication/200098 Notice: Changes introduced as a result of publishing processes such as copy-editing and formatting may not be reflected in this document. For a definitive version of this work, please refer to the published source. Please note that access to the published version might require a subscription. Chalmers Publication Library (CPL) offers the possibility of retrieving research publications produced at Chalmers University of Technology. It covers all types of publications: articles, dissertations, licentiate theses, masters theses, conference papers, reports etc. Since 2006 it is the official tool for Chalmers official publication statistics. To ensure that Chalmers research results are disseminated as widely as possible, an Open Access Policy has been adopted. The CPL service is administrated and maintained by Chalmers Library. (article starts on next page) ARTICLE Genome Scale Metabolic Modeling of the - 
												
												A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. - 
												
												Pan-Cancer Analysis Identifies Mutations in SUGP1 That Recapitulate Mutant SF3B1 Splicing Dysregulation
Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation Zhaoqi Liua,b,c,1, Jian Zhangd,1, Yiwei Suna,c, Tomin E. Perea-Chambleea,b,c, James L. Manleyd,2, and Raul Rabadana,b,c,2 aProgram for Mathematical Genomics, Columbia University, New York, NY 10032; bDepartment of Systems Biology, Columbia University, New York, NY 10032; cDepartment of Biomedical Informatics, Columbia University, New York, NY 10032; and dDepartment of Biological Sciences, Columbia University, New York, NY 10027 Contributed by James L. Manley, March 2, 2020 (sent for review January 2, 2020; reviewed by Kristen Lynch and Gene Yeo) The gene encoding the core spliceosomal protein SF3B1 is the most also resulted in the same splicing defects observed in SF3B1 frequently mutated gene encoding a splicing factor in a variety of mutant cells (11). hematologic malignancies and solid tumors. SF3B1 mutations in- In addition to SF3B1, other SF-encoding genes have also been duce use of cryptic 3′ splice sites (3′ss), and these splicing errors found to be mutated in hematologic malignancies, e.g., U2AF1, contribute to tumorigenesis. However, it is unclear how wide- SRSF2, and ZRSR2. However, these SF gene mutations do not spread this type of cryptic 3′ss usage is in cancers and what is share common alterations in splicing (1, 3), suggesting that dif- the full spectrum of genetic mutations that cause such missplicing. ferent splicing patterns may contribute to different phenotypes To address this issue, we performed an unbiased pan-cancer anal- of cancers. Because SF3B1 is the most frequently mutated ysis to identify genetic alterations that lead to the same aberrant splicing gene, the splicing defects caused by mutant SF3B1 may SF3B1 splicing as observed with mutations. - 
												
												Nuclear PTEN Safeguards Pre-Mrna Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role
ARTICLE DOI: 10.1038/s41467-018-04760-1 OPEN Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role Shao-Ming Shen1, Yan Ji2, Cheng Zhang1, Shuang-Shu Dong2, Shuo Yang1, Zhong Xiong1, Meng-Kai Ge1, Yun Yu1, Li Xia1, Meng Guo1, Jin-Ke Cheng3, Jun-Ling Liu1,3, Jian-Xiu Yu1,3 & Guo-Qiang Chen1 Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are 1234567890():,; largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers. 1 Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. 2 Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and SJTU-SM, Shanghai 200025, China. - 
												
												Comparative Genomics of Biotechnologically Important Yeasts Supplementary Appendix
Comparative genomics of biotechnologically important yeasts Supplementary Appendix Contents Note 1 – Summary of literature on ascomycete yeasts used in this study ............................... 3 CUG-Ser yeasts ................................................................................................................................................................ 3 Other Saccharomycotina ............................................................................................................................................. 5 Taphrinomycotina ....................................................................................................................................................... 10 Note 2 – Genomes overview .................................................................................................11 Yeast culturing, identification, DNA and total RNA extraction ................................................................. 12 Genome sequencing and assembly ....................................................................................................................... 12 Transcriptome sequencing and assembly ......................................................................................................... 13 Table S1. Genome statistics ..................................................................................................................................... 14 Table S2. Annotation statistics .............................................................................................................................. - 
												
												HNRNPA1 Promotes Recognition of Splice Site Decoys by U2AF2 in Vivo
Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Research HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo Jonathan M. Howard,1,5 Hai Lin,2,5 Andrew J. Wallace,1 Garam Kim,1 Jolene M. Draper,1 Maximilian Haeussler,3 Sol Katzman,3 Masoud Toloue,4 Yunlong Liu,2 and Jeremy R. Sanford1 1Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, California 95064, USA; 2Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA; 3Center for Biomolecular Science and Engineering, University of California Santa Cruz, Santa Cruz, California 95064, USA; 4Bioo Scientific Corporation, Austin, Texas 78744, USA Alternative pre-mRNA splicing plays a major role in expanding the transcript output of human genes. This process is regulated, in part, by the interplay of trans-acting RNA binding proteins (RBPs) with myriad cis-regulatory elements scat- tered throughout pre-mRNAs. These molecular recognition events are critical for defining the protein-coding sequences (exons) within pre-mRNAs and directing spliceosome assembly on noncoding regions (introns). One of the earliest events in this process is recognition of the 3′ splice site (3′ss) by U2 small nuclear RNA auxiliary factor 2 (U2AF2). Splicing reg- ulators, such as the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), influence spliceosome assembly both in vitro and in vivo, but their mechanisms of action remain poorly described on a global scale. HNRNPA1 also promotes proofread- ing of 3′ss sequences though a direct interaction with the U2AF heterodimer. - 
												
												Ashbya Gossypii
A role of actin-regulatory proteins in the formation of needle-shaped spores in the filamentous fungus Ashbya gossypii Dissertation zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) Fachbereich Biologie/Chemie der Universität Osnabrück vorgelegt von Manuela Lickfeld Osnabrück, im März 2012 Table of contents 1 Summary 1 2 Introduction 3 2.1 Ashbya gossypii - a model for the investigation of cell biological processes 3 2.2 Sporulation in ascomycetes 7 2.3 The role of actin in spore development 11 2.4 Aims of this study 14 3 Results 21 3.1 A Bnr-like formin links actin to the spindle pole body during sporulation in the 23 filamentous fungus Ashbya gossypii M. Kemper, L. Mohlzahn, M. Lickfeld, C. Lang, S. Wählisch & H.P. Schmitz, (2011) Molecular Microbiology 80: 1276-1295 3.2 Selection of STOP-free sequences from random mutagenesis for 51 ދloss of interactionތ two-hybrid studies Lickfeld, M. & H.P. Schmitz, (2011) Yeast 28: 535-545. 3.3 A network involving Rho-type GTPases, a Paxillin and a Formin homolog 65 regulates spore length and spore wall integrity in the filamentous fungus Ashbya gossypii Lickfeld, M. & H.P. Schmitz, (2012) manuscript submitted 3.4 Dissection of Rho-GTPase function in polar growth and sporulation of 111 Ashbya gossypii Lickfeld, M. & H.P. Schmitz, (2012) manuscript in preparation 4 Concluding remarks 141 5 Appendix 145 5.1 The AgPXL1 deletion and overexpression strains show septation defects 145 5.2 AgPrk1 is essential in A. gossypii 146 6 Abbreviations 149 7 Anlage 1 151 8 Danksagung 153 1 Summary 1 Summary Spore formation is an essential step in the fungal life cycle that contributes to the dispersal of the organism and also to survival under harsh environmental conditions. - 
												
												Genome Sequence of the Lignocellulose-Bioconverting and Xylose-Fermenting Yeast Pichia Stipitis
ARTICLES Genome sequence of the lignocellulose-bioconverting and xylose-fermenting yeast Pichia stipitis Thomas W Jeffries1,2,8, Igor V Grigoriev3,8, Jane Grimwood4, Jose´ M Laplaza1,5, Andrea Aerts3, Asaf Salamov3, Jeremy Schmutz4, Erika Lindquist3, Paramvir Dehal3, Harris Shapiro3, Yong-Su Jin6, Volkmar Passoth7 & Paul M Richardson3 Xylose is a major constituent of plant lignocellulose, and its fermentation is important for the bioconversion of plant biomass to fuels and chemicals. Pichia stipitis is a well-studied, native xylose-fermenting yeast. The mechanism and regulation of xylose metabolism in P. stipitis have been characterized and genes from P. stipitis have been used to engineer xylose metabolism in Saccharomyces cerevisiae. We have sequenced and assembled the complete genome of P. stipitis. The sequence data have revealed unusual aspects of genome organization, numerous genes for bioconversion, a preliminary insight into regulation of central metabolic pathways and several examples of colocalized genes with related functions. http://www.nature.com/naturebiotechnology The genome sequence provides insight into how P. stipitis regulates its redox balance while very efficiently fermenting xylose under microaerobic conditions. Xylose is a five-carbon sugar abundant in hardwoods and agri- RESULTS cultural residues1, so its fermentation is essential for the economic The 15.4-Mbp genome of P. stipitis was sequenced using a shotgun conversion of lignocellulose to ethanol2. Pichia stipitis Pignal (1967) is approach and finished to high quality (o1 error in 100,000). The a haploid, homothallic, hemiascomycetous yeast3,4 that has the eight chromosomes range in size from 3.5 to 0.97 Mbp, as previously highest native capacity for xylose fermentation of any known reported16. - 
												
												Control of Pre-Mrna Splicing by the General Splicing Factors PUF60 and U2AF 65 M Hastings, Eric Allemand, D Duelli, M
Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF 65 M Hastings, Eric Allemand, D Duelli, M. Myers, A. R. Krainer To cite this version: M Hastings, Eric Allemand, D Duelli, M. Myers, A. R. Krainer. Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF 65. PLoS ONE, Public Library of Science, 2007, 2 (6), pp.e538. 10.1371/journal.pone.0000538. hal-02462773 HAL Id: hal-02462773 https://hal.archives-ouvertes.fr/hal-02462773 Submitted on 31 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF65 Michelle L. Hastings, Eric Allemand¤, Dominik M. Duelli, Michael P. Myers, Adrian R. Krainer* Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America Pre-mRNA splicing is a crucial step in gene expression, and accurate recognition of splice sites is an essential part of this process. Splice sites with weak matches to the consensus sequences are common, though it is not clear how such sites are efficiently utilized. Using an in vitro splicing-complementation approach, we identified PUF60 as a factor that promotes splicing of an intron with a weak 39 splice-site. - 
												
												Large-Scale Analysis of Genome and Transcriptome Alterations in Multiple Tumors Unveils Novel Cancer-Relevant Splicing Networks
Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks Endre Sebestyén1,*, Babita Singh1,*, Belén Miñana1,2, Amadís Pagès1, Francesca Mateo3, Miguel Angel Pujana3, Juan Valcárcel1,2,4, Eduardo Eyras1,4,5 1Universitat Pompeu Fabra, Dr. Aiguader 88, E08003 Barcelona, Spain 2Centre for Genomic Regulation, Dr. Aiguader 88, E08003 Barcelona, Spain 3Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), E08908 L’Hospitalet del Llobregat, Spain. 4Catalan Institution for Research and Advanced Studies, Passeig Lluís Companys 23, E08010 Barcelona, Spain *Equal contribution 5Correspondence to: [email protected] Keywords: alternative splicing, RNA binding proteins, splicing networks, cancer 1 Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Alternative splicing is regulated by multiple RNA-binding proteins and influences the expression of most eukaryotic genes. However, the role of this process in human disease, and particularly in cancer, is only starting to be unveiled. We systematically analyzed mutation, copy number and gene expression patterns of 1348 RNA-binding protein (RBP) genes in 11 solid tumor types, together with alternative splicing changes in these tumors and the enrichment of binding motifs in the alternatively spliced sequences. Our comprehensive study reveals widespread alterations in the expression of RBP genes, as well as novel mutations and copy number variations in association with multiple alternative splicing changes in cancer drivers and oncogenic pathways. Remarkably, the altered splicing patterns in several tumor types recapitulate those of undifferentiated cells. - 
												
												Six Key Traits of Fungi: Their Evolutionary Origins and Genetic Bases LÁSZLÓ G
Six Key Traits of Fungi: Their Evolutionary Origins and Genetic Bases LÁSZLÓ G. NAGY,1 RENÁTA TÓTH,2 ENIKŐ KISS,1 JASON SLOT,3 ATTILA GÁCSER,2 and GÁBOR M. KOVÁCS4,5 1Synthetic and Systems Biology Unit, Institute of Biochemistry, HAS, Szeged, Hungary; 2Department of Microbiology, University of Szeged, Szeged, Hungary; 3Department of Plant Pathology, Ohio State University, Columbus, OH 43210; 4Department of Plant Anatomy, Institute of Biology, Eötvös Loránd University, Budapest, Hungary; 5Plant Protection Institute, Center for Agricultural Research, Hungarian Academy of Sciences, Budapest, Hungary ABSTRACT The fungal lineage is one of the three large provides an overview of some of the most important eukaryotic lineages that dominate terrestrial ecosystems. fungal traits, how they evolve, and what major genes They share a common ancestor with animals in the eukaryotic and gene families contribute to their development. The supergroup Opisthokonta and have a deeper common ancestry traits highlighted here represent just a sample of the with plants, yet several phenotypes, such as morphological, physiological, or nutritional traits, make them unique among characteristics that have evolved in fungi, including po- all living organisms. This article provides an overview of some of larized multicellular growth, fruiting body development, the most important fungal traits, how they evolve, and what dimorphism, secondary metabolism, wood decay, and major genes and gene families contribute to their development. mycorrhizae. However, a great deal of other important The traits highlighted here represent just a sample of the traits also underlie the evolution of the taxonomically characteristics that have evolved in fungi, including polarized and phenotypically hyperdiverse fungal kingdom, which multicellular growth, fruiting body development, dimorphism, could fill up a volume on its own.